Simplex Trading
LSTA icon

Simplex Trading’s Lisata Therapeutics LSTA Stock Holding History

Simplex Trading’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,160
Closed -$41K – 10474
2022
Q2 		$41K Sell
5,160
-2,740
-35% -$22.6K ﹤0.01% 6737
2022
Q1 		$85K Sell
7,900
-22,760
-74% -$260K ﹤0.01% 6380
2021
Q4 		$387K Buy
30,660
+10,320
+51% +$159K ﹤0.01% 4180
2021
Q3 		$479K Hold
20,340
– – ﹤0.01% 4167
2021
Q2 		$491K Buy
20,340
+20,093
+8,135% +$476K ﹤0.01% 4202
2021
Q1 		$716K Buy
247
+220
+815% +$6.67K ﹤0.01% 2848
2020
Q4 		$57K Hold
27
– – ﹤0.01% 6036
2020
Q3 		$72K Sell
27
-26
-49% -$822 ﹤0.01% 5252
2020
Q2 		$142K Buy
+53
New +$1.56K ﹤0.01% 4403
2018
Q3 		– Sell
-3
Closed -$29K – 7763
2018
Q2 		$29K Buy
+3
New +$212 ﹤0.01% 5569

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CW
Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's LSTA Position: Q2 2022 in Review

Simplex Trading sold out of Lisata Therapeutics (LSTA) in Q2 2022, closing a stake of 1,259 shares — an estimated $10.4K sold.

Simplex Trading first reported a position in LSTA in Q4 2014 and held it in 10 quarters. The position peaked at $21K in Q4 2020. 34 funds tracked by Wall St. Rank hold LSTA as of Q2 2022.

  • Simplex Trading reported no remaining Lisata Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Simplex Trading sold 1,259 Lisata Therapeutics shares in Q2 2022, an estimated $10.4K.
  • Simplex Trading first reported a position in Lisata Therapeutics in Q4 2014 and held it in 10 quarters.
  • Simplex Trading's Lisata Therapeutics position peaked at $21K in Q4 2020.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.